Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quantum-Si Incorporated - Class A Common Stock (NQ:QSI)

2.140 +0.160 (+8.08%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quantum-Si Incorporated - Class A Common Stock

< Previous 1 2 3 4 5 Next >
Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event
From Quantum-Si Incorporated
Via Business Wire
Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si and Planet Innovation to Partner on Proteus™
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Reports Third Quarter 2024 Financial Results
From Quantum-Si Incorporated
Via Business Wire
University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si’s Next-Gen Protein Sequencer™ Platinum®
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Participate in Upcoming Investment Conferences
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024
From Quantum-Si Incorporated
Via Business Wire
Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
From Quantum-Si Incorporated
Via Business Wire
Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development
From Quantum-Si Incorporated
Via Business Wire
CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Reports Second Quarter 2024 Financial Results
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Announces Presentations at ASMS and ESHG
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Reports First Quarter 2024 Financial Results
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
From Quantum-Si Incorporated
Via Business Wire
Penny Stock Quantum-Si Incorporated Readies For Lift-Off
Quantum-Si is entering a hyper-growth phase with the full-scale launch of its Platinum gene sequencing device. Analysts' sentiment supports the market. 
Via MarketBeat
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.